Achievement of a normal level of fecal calprotectin within a year of diagnosis of Crohn’s disease is associated with a reduced risk for progression of the condition, researchers have found.
Studies have shown that fecal calprotectin is highly correlated with endoscopic inflammation (Can J Gastroenterol Hepatol 2015;29[7]:369-372). In the new study, led by Nikolas Plevris, MD, a clinical research fellow at the University of Edinburgh, in Scotland, researchers sought to determine whether